Multiple Myeloma: State of the Art

The treatment of newly diagnosed myeloma is a moving target given the rapid and important advances in the understanding of disease biology as well as a wealth of new agents with which to treat the disease. As such, it is important at the time of initial presentation, to have a defined treatment plan that includes induction, consolidation and maintenance therapy in order to maximize duration of initial response. Along the same lines, in the relapsed disease setting, following defined treatment approaches allows one to maximize treatment benefit and prolong duration of subsequent remissions.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Sagar Lonial Source Type: research